Publications by authors named "Maria Genalin Angelo"

Claim this Profile
R
Results on exposure during pregnancy from a pregnancy registry for AS04-HPV-16/18 vaccine.
Marta López-Fauqued, Julia Zima, Maria-Genalin Angelo, Jens-Ulrich Stegmann

Vaccine· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial.
Matti Lehtinen, Tiina Eriksson, Dan Apter, Mari Hokkanen, Kari Natunen, Maria-Genalin Angelo

Hum Vaccin Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.
Corinne Willame, Dominique Rosillon, Julia Zima, Maria-Genalin Angelo, Anke L Stuurman

Hum Vaccin Immunother· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.
Laurence Baril, Dominique Rosillon, Corinne Willame, Maria Genalin Angelo, Julia Zima

Vaccine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.
Frank Huygen, Kristin Verschueren, Candida McCabe, Jens-Ulrich Stegmann, Julia Zima, Maria-Genalin Angelo

EBioMedicine· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for continuous evaluation of the benefit-risk profile of HPV-16/18-AS04-adjuvanted vaccine.
Maria-Genalin Angelo, Sylvia Taylor, Frank Struyf, Fernanda Tavares Da Silva, Felix Arellano

Expert Rev Vaccines· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme.
Maria-Genalin Angelo, Marie-Pierre David, Julia Zima, Laurence Baril, Gary Dubin

Pharmacoepidemiol Drug Saf· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience.
Maria-Genalin Angelo, Julia Zima, Fernanda Tavares Da Silva, Laurence Baril, Felix Arellano

Pharmacoepidemiol Drug Saf· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis